Auna SA(AUNA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 87.91 | EPS (ttm) | 0.05 | Insider Own | 63.25% | Shs Outstand | 30.1M | Perf Week | -4.57% |
| Market Cap | 0.36B | Forward P/E | 4.82 | EPS next Y | 31.54% | Insider Trans | 0.14% | Shs Float | 27.2M | Perf Month | -3.61% |
| Enterprise Value | 1.36B | PEG | 120.39 | EPS next Q | 0.26 | Inst Own | 25.49% | Short Float | 1.6% | Perf Quarter | -5.33% |
| Income | 0.00B | P/S | 0.26 | EPS this Y | -39.87% | Inst Trans | -1.9% | Short Ratio | 2.55 | Perf Half Y | -5.33% |
| Sales | 1.36B | P/B | 0.65 | EPS next 5Y | 0.04% | ROA | 0.19% | Short Interest | 0.43M | Perf YTD | -2.44% |
| Book/sh | 7.37 | P/C | 2.52 | EPS past 3/5Y | - | ROE | 0.81% | 52W High | -23.69% ($6.29) | Perf Year | -18.92% |
| Cash/sh | 1.91 | P/FCF | 3.02 | Sales past 3/5Y | 24.37% 24.38% | ROIC | 0.27% | 52W Low | 17.36% ($4.09) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 5.76 | EPS Y/Y TTM | -93.67% | Gross Margin | 36.89% | Volatility(W/M) | 3.68% 2.81% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1 | Sales Y/Y TTM | 16.82% | Oper. Margin | 12.51% | ATR (14) | 0.18 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1 | EPS Q/Q | -61.75% | Profit Margin | 0.3% | RSI (14) | 37.01 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.08 | Sales Q/Q | 20.64% | SMA20 | -6.53% ($5.14) | Beta | 0.62 | Target Price | $7.53 |
| Payout | - | Debt/Eq | 2.01 | Earnings | 2026/11/17 | SMA50 | -6.91% ($5.16) | Rel Volume | 0.57 | Prev Close | $4.74 |
| Employees | 15254 | LT Debt/Eq | 1.77 | EPS/Sales Surpr. | -44.24% 2.57% | SMA200 | -6.3% ($5.12) | Avg Volume(3M) | 0.17M | Price | $4.8 |
| IPO | 2024/3/22 | Option/Short | No/Yes | Trades | 698 | Volume | 97,269 | Change | 1.27% |
A Latin American healthcare facilities company operating hospital and clinic networks in Peru, Mexico, and Colombia, along with prepaid healthcare plans. It focuses on the treatment of complex conditions such as cancer (oncology), cardiac, and neurological diseases, while also offering a prevention-based model through Oncosalud, its prepaid healthcare plan in Peru.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
Traded less than usual. That is 57% of its average volume.
Next earnings report: November 17
AUNA earns at a steady pace
Of every $100 in sales, $12.51 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -39.9% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $576. Peers typically go for $1,321.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 25.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #35 of 48 in the industry
Based on market cap of $355M.
FAQ
What kind of company is AUNA?
AUNA belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of AUNA?
The market cap of AUNA is approximately $355M, ranking 3,472 within its sector.
What is the P/E ratio of AUNA?
AUNA has a P/E ratio of approximately 87.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for AUNA?
AUNA has recorded a 52-week high of $6.29 and a low of $4.09.
